tradingkey.logo
tradingkey.logo
Search

Aclaris Therapeutics Inc

ACRS
Add to Watchlist
5.250USD
+0.050+0.96%
Close 07-31 16:00ETQuotes delayed by 15 min
733.18MMarket Cap
LossP/E TTM

ACRS Financials

See Aclaris Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Aclaris Therapeutics Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-0.15/-0.16
Revenue / Forecast
2.00M/1.32M
Period
FY2025 Earnings
Revenue(YoY)
7.83M
-58.19%
EPS(YoY)
-0.53
69.00%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-24.87%-0.15
84.05%-0.16
-12.15%-0.12
18.32%-0.13
48.29%-0.12
-4708.37%-1.01
74.28%-0.11
63.19%-0.15
43.40%-0.24
94.92%-0.02
---0.41
---0.42
---0.42
---0.41
---0.92
----
----
----
----
----
Revenue
37.18%2.00M
-85.94%1.29M
-24.09%3.30M
-35.76%1.78M
-39.32%1.46M
-47.58%9.21M
-53.18%4.35M
47.99%2.77M
-5.14%2.40M
126.62%17.57M
-51.19%9.28M
22.32%1.87M
73.98%2.53M
416.52%7.75M
1046.35%19.02M
-16.23%1.53M
-18.23%1.45M
-5.00%1.50M
14.49%1.66M
-10.85%1.82M
Net Profit
-31.42%-19.82M
79.50%-19.80M
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-6375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
94.60%-1.49M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
-21.18%-27.64M
5.65%-19.95M
-13.06%-20.53M
34.66%-18.79M
-73.11%-22.80M
-98.39%-21.15M
-56.60%-18.16M
Net Margin
4.20%-993.19%
-45.82%-1528.57%
-153.78%-442.98%
-118.61%-868.26%
-46.75%-1036.77%
-12252.32%-1048.22%
44.63%-174.55%
74.90%-397.18%
36.58%-706.46%
97.62%-8.49%
---315.24%
---1582.08%
---1113.92%
---356.44%
---269.43%
----
----
----
----
----
Gross Margin
348.56%10.42%
-1275.13%-13.44%
-42.22%25.77%
-113.26%-4.11%
-118.02%-4.19%
-101.54%-0.98%
279.73%44.59%
109.05%30.98%
-10.74%23.27%
-21.20%63.41%
--11.74%
--14.82%
--26.07%
--80.47%
--52.52%
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
----
--0.00%
----
----
----
----
----
Revenue
37.18%2.00M
-85.94%1.29M
-24.09%3.30M
-35.76%1.78M
-39.32%1.46M
-47.58%9.21M
-53.18%4.35M
47.99%2.77M
-5.14%2.40M
126.62%17.57M
-51.19%9.28M
22.32%1.87M
73.98%2.53M
416.52%7.75M
1046.35%19.02M
-16.23%1.53M
-18.23%1.45M
-5.00%1.50M
14.49%1.66M
-10.85%1.82M
Operating profit
-24.79%-22.19M
-58.73%-22.33M
-76.29%-17.05M
-33.62%-16.91M
-10.25%-17.78M
40.68%-14.07M
67.31%-9.67M
62.02%-12.65M
47.49%-16.13M
-7.91%-23.72M
-58.42%-29.58M
-36.57%-33.31M
-52.77%-30.72M
-6.21%-21.98M
3.72%-18.67M
-84.72%-24.39M
-66.31%-20.11M
-52.60%-20.69M
-85.33%-19.39M
-16.04%-13.21M
Net Profit
-31.42%-19.82M
79.50%-19.80M
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-6375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
94.60%-1.49M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
-21.18%-27.64M
5.65%-19.95M
-13.06%-20.53M
34.66%-18.79M
-73.11%-22.80M
-98.39%-21.15M
-56.60%-18.16M
Current assets
1.32%110.23M
-23.53%96.32M
-23.98%100.59M
-11.42%104.20M
-19.62%108.79M
-2.25%125.95M
7.53%132.33M
-11.51%117.64M
-26.59%135.34M
-44.35%128.86M
-52.03%123.07M
-48.74%132.94M
-3.42%184.36M
12.93%231.55M
24.68%256.57M
7.50%259.35M
41.92%190.88M
256.62%205.03M
254.81%205.78M
240.02%241.26M
Total current liabilities
27.22%27.37M
-9.34%28.64M
36.22%25.63M
71.15%26.84M
7.14%21.51M
2.08%31.60M
-31.13%18.82M
-31.31%15.68M
9.98%20.08M
41.09%30.95M
38.06%27.32M
40.77%22.83M
9.16%18.26M
-4.33%21.94M
10.93%19.79M
8.72%16.22M
15.31%16.73M
54.17%22.93M
39.50%17.84M
-15.94%14.92M
Total assets
0.32%198.72M
-27.17%160.46M
-3.76%175.53M
17.43%189.15M
13.80%198.09M
11.61%220.33M
-16.47%182.39M
-31.65%161.07M
-24.22%174.06M
-22.46%197.41M
-18.41%218.35M
-15.23%235.65M
1.40%229.71M
1.35%254.60M
1.57%267.63M
-3.50%277.98M
40.35%226.53M
254.90%251.21M
266.46%263.49M
238.88%288.05M
Total liabilities
1.93%55.07M
-11.42%57.38M
6.11%55.43M
110.68%57.41M
68.57%54.03M
61.02%64.77M
-15.77%52.24M
-51.25%27.25M
-39.41%32.05M
-29.40%40.23M
29.77%62.02M
32.39%55.90M
14.18%52.90M
5.76%56.98M
1.88%47.79M
-22.14%42.22M
-5.66%46.33M
62.58%53.87M
50.63%46.91M
52.19%54.23M
Total equity
-0.29%143.65M
-33.73%103.08M
-7.72%120.10M
-1.56%131.74M
1.44%144.07M
-1.03%155.55M
-16.75%130.15M
-25.55%133.82M
-19.68%142.01M
-20.46%157.18M
-28.89%156.33M
-23.75%179.75M
-1.88%176.81M
0.14%197.62M
1.50%219.84M
0.83%235.75M
60.47%180.20M
424.15%197.34M
431.40%216.58M
373.64%233.81M
Net operating income
-39.00%-18.15M
-46.91%-13.13M
-149.69%-10.93M
18.90%-9.99M
37.27%-13.06M
-32.20%-8.94M
189.59%22.00M
40.34%-12.32M
21.01%-20.82M
64.63%-6.76M
-214.15%-24.56M
-5.02%-20.65M
-25.68%-26.35M
-11.95%-19.11M
26.30%-7.82M
-60.92%-19.67M
-71.43%-20.97M
-92.79%-17.07M
12.71%-10.61M
-12.94%-12.22M
Net investment
-261.79%-30.93M
111.69%10.37M
394.81%13.83M
848.81%5.05M
13.58%19.12M
-1275.14%-88.72M
-91.41%2.79M
96.57%-674.00K
-34.75%16.83M
179.42%7.55M
2573.29%32.53M
7.36%-19.66M
-13.81%25.80M
129.45%2.70M
103.23%1.22M
53.33%-21.22M
139.74%29.93M
-298.09%-9.18M
-819.34%-37.67M
-333.58%-45.47M
Net financing
21111.27%57.78M
-103.40%-2.53M
-13936.36%-3.04M
18.18%-9.00K
-400.00%-275.00K
152104.08%74.58M
125.29%22.00K
-100.04%-11.00K
---55.00K
32.43%49.00K
-690.91%-87.00K
-63.27%26.74M
-100.00%0.00
1950.00%37.00K
99.90%-11.00K
-46.41%72.81M
-99.97%30.00K
-100.03%-2.00K
-4060.79%-11.57M
140173.20%135.87M

FAQs

What is the total revenue of Aclaris Therapeutics Inc?

According to Aclaris Therapeutics Inc's FY2025 earnings report, its total revenue reached 7.83M, with a year-on-year change of 18.72M.

What are the current assets of Aclaris Therapeutics Inc?

According to Aclaris Therapeutics Inc's FY2025 earnings report, its current assets were 96.32M, with a year-on-year change of -23.53.

What are the total assets of Aclaris Therapeutics Inc?

According to Aclaris Therapeutics Inc's FY2025 earnings report, its total assets of Aclaris Therapeutics Inc were 160.46M, with a year-on-year change of -27.17.

What are the total liabilities of Aclaris Therapeutics Inc?

According to Aclaris Therapeutics Inc's FY2025 earnings report, its total liabilities of Aclaris Therapeutics Inc were 57.38M, with a year-on-year change of -11.42.

What is the total equity of Aclaris Therapeutics Inc?

According to Aclaris Therapeutics Inc's FY2025 earnings report, its total equity of Aclaris Therapeutics Inc was 103.08M, with a year-on-year change of -33.73.

What is the net operating income of Aclaris Therapeutics Inc?

According to Aclaris Therapeutics Inc's FY2025 earnings report, its net operating income of Aclaris Therapeutics Inc was -74.08M, with a year-on-year change of -48.66.

What is the net investment of Aclaris Therapeutics Inc?

According to Aclaris Therapeutics Inc's FY2025 earnings report, its net investment of Aclaris Therapeutics Inc was 48.37M, with a year-on-year change of 169.32.

What is the net financing of Aclaris Therapeutics Inc?

According to Aclaris Therapeutics Inc's FY2025 earnings report, its net financing of Aclaris Therapeutics Inc was -5.86M, with a year-on-year change of -107.86.

What is the Earnings Per Share (EPS) of Aclaris Therapeutics Inc?

According to Aclaris Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.53, with a year-on-year change of 69.00.

What is the net income of Aclaris Therapeutics Inc?

According to Aclaris Therapeutics Inc's FY2025 earnings report, its net income was -64.92M, with a year-on-year change of 50.84.

What is the net margin of Aclaris Therapeutics Inc?

According to Aclaris Therapeutics Inc's FY2025 earnings report, its net profit margin was -829.58, with a year-on-year change of -17.59.

What is the gross margin of Aclaris Therapeutics Inc?

According to Aclaris Therapeutics Inc's FY2025 earnings report, its gross margin was 6.93, with a year-on-year change of -62.55.

What is the Return on Equity (ROE) of Aclaris Therapeutics Inc?

According to Aclaris Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -50.20, with a year-on-year change of 40.56.

What is the Return on Assets (ROA) of Aclaris Therapeutics Inc?

According to Aclaris Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -34.10, with a year-on-year change of 46.07.

What is the operating profit of Aclaris Therapeutics Inc?

According to Aclaris Therapeutics Inc's FY2025 earnings report, its operating profit was -74.08M, with a year-on-year change of -48.66.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.